Inscription Capital, LLC Novartis Ag Transaction History

Inscription Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$81.78 - $95.14 $556,594 - $647,522	-6,806 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $580,143 - $640,784	6,806 New	6,806 $621,000
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $280,918 - $311,220	-3,420 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $89,994 - $101,303	-1,112 Reduced 24.54%	3,420 $299,000
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $10,388 - $14,554	-147 Reduced 3.14%	4,532 $374,000
Q4 2019 Feb 04, 2020	SELL	$84.35 - $95.37 $2,108 - $2,384	-25 Reduced 0.53%	4,679 $443,000
Q3 2019 Nov 01, 2019	SELL	$85.54 - $94.26 $46,448 - $51,183	-543 Reduced 10.35%	4,704 $409,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $67,181 - $82,684	-891 Reduced 14.52%	5,247 $476,000
Q1 2019 May 16, 2019	SELL	$75.32 - $86.15 $15,817 - $18,091	-210 Reduced 3.31%	6,138 $590,000
Q4 2018 May 16, 2019	BUY	$73.66 - $82.02 $467,593 - $520,662	6,348 New	6,348 $545,000

1,426

138M

1.48M

1.54M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Inscription Capital, LLC with notifications on news.